Prevalence of microalbuminuria in recently diagnosed Type 2 diabetes mellitus and its relationship to non-traditional risk factors: observations from the ADOPT study by Viberti, G, Freed, M, Holman, R, Lachin, J, Heise, M, Grp, A

Levels of beta-cell dysfunction and insulin resistance differ between Europeans and North Americans with recently-diagnosed diabetes in the ADOPT study by Holman, R, Kahn, SE, Heise, M, Porter, L, Freed, M, Grp, A

Neural Transplantation of hNT Neurons for Huntington's Disease by Marc S. Hurlbert, Rocio I. Gianani, Cynthia Hutt, Curt R. Freed M.D., Farida G. Kaddis

Get full text

Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. by Kahn, SE, Zinman, B, Haffner, S, O'Neill, M, Kravitz, BG, Yu, D, Freed, M, Herman, W, Holman, R, Jones, N, Lachin, J, Viberti, G

A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2... by Viberti, G, Kahn, SE, Greene, D, Herman, W, Zinman, B, Holman, R, Haffner, S, Levy, D, Lachin, J, Berry, R, Heise, M, Jones, N, Freed, M

A Diabetes Outcome Progression Trial (ADOPT): An international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2... by Viberti, G, Kahn, SE, Greene, D, Herman, W, Zinman, B, Holman, R, Haffner, S, Levy, D, Lachin, J, Berry, R, Heise, M, Jones, N, Freed, M

“I finally felt i had the tools to control these urges”: empowering students to achieve their device use goals with the reduce digital distraction workshop by Lyngs, U, Lukoff, K, Slovak, P, Inzlicht, M, Freed, M, Andrews, H, Tinsman, C, Csuka, L, Alberts, L, Oldemburgo de Mello, V, Makransky, G, Hornbæk, K, Van Kleek, M, Shadbolt, N